Mentoring Translational Cancer Research in Oklahoma
Project Number1P30GM154635-01
Contact PI/Project LeaderDHANASEKARAN, DANNY N.
Awardee OrganizationUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
Description
Abstract Text
Abstract
Oklahoma faces a significant burden of cancer, with a high incidence and mortality rate. The impact of cancer is
particularly profound among diverse communities, including Native American populations, making it a pressing
concern for our state. Cancer poses a substantial challenge to the health and well-being of our residents, placing
considerable social and economic strain on Oklahoma. The primary objective of this COBRE is to advance
cancer research in Oklahoma. During Phase I and Phase II, our COBRE demonstrated remarkable progress.
Supported Research Project Leaders secured competitive grants, including NIH R01 awards, Department of
Defense grants, and esteemed foundation grants such as the American Cancer Society. Of the total of 375
papers that were published with acknowledgment to our COBRE, COBRE Research Project Leaders and Pilot
Project Leaders authored 246 papers, all of them benefiting from COBRE and COBRE-funded Core support.
The COBRE-supported Cores played a vital role in supporting multiple Investigators, facilitating publications,
and aiding in acquiring federal grants, enriching cancer research in Oklahoma. Phase III seeks to build on this
success, emphasizing sustainability and growth. For Phase III of the COBRE program, our vision is to build upon
our prior achievements, fostering sustainability and growth. We remain dedicated to mentoring and supporting
graduated Research Project Leaders. Our goal is to enhance Core facilities to accommodate evolving cancer
research needs, transitioning them into institutional cancer research Cores. Committed to fostering cross-
disciplinary collaboration and translational research, Phase III COBRE will innovate through the Pilot Grants
Program. These concerted efforts are poised to further advance cancer research in our region, moving us closer
to the coveted designation of a Comprehensive Cancer Center status for our NCI-designated cancer center. The
establishment of such a center will revolutionize cancer prevention and treatment, benefiting our community and
beyond. This Phase III COBRE marks a significant stride toward realizing our vision of a future free from the
burden of cancer, where advanced research and improved clinical practices lead to better outcomes for all.
Public Health Relevance Statement
Project Narrative:
Cancer research is a strategic area of research at the University of Oklahoma Health Sciences Center. The
overarching objective of COBRE Phase III is to provide continued support for cancer researchers in Oklahoma
by bolstering the research infrastructure dedicated to cancer research. We anticipate that the endeavors
undertaken through COBRE Phase III will propel groundbreaking advancements in cancer prevention and
treatment, offering hope and transformative treatments to cancer patients in Oklahoma.
1
NIH Spending Category
No NIH Spending Category available.
Project Terms
AchievementAddressAdvanced Malignant NeoplasmAdvisory CommitteesAffectAmerican Cancer SocietyAreaAwardCancer BurdenCancer CenterCancer PatientCancer Research InfrastructureCenters of Research ExcellenceCollaborationsCommunitiesCommunity OutreachComprehensive Cancer CenterCore FacilityDataDeath RateDedicationsDepartment of DefenseDiseaseDisparityEconomic BurdenEconomicsEducationEnsureEtiologyFaceFeesFosteringFoundationsFundingFutureGoalsGrantGrowthHealthHealth SciencesHigh PrevalenceIncidenceInstitutionLeadLeadershipMalignant NeoplasmsMentorsMentorshipMissionNCI-Designated Cancer CenterNative American populationNewly DiagnosedOklahomaOutcomePaperPersonal SatisfactionPhasePilot ProjectsPlayPopulationPublicationsPublishingResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleSecureServicesSpecial PopulationStatutes and LawsStrategic PlanningTalentsTherapeuticTranslational ResearchUnited States National Institutes of HealthUniversitiesVisionanti-cancer researchcancer diagnosiscancer preventioncancer therapyclinical applicationclinical practicedesignempowermentglobal healthhealth disparityimprovedinnovationprogramsrecruitresearch facilityrural areasocialsuccesstranslational cancer researchunderserved area
No Sub Projects information available for 1P30GM154635-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P30GM154635-01
Patents
No Patents information available for 1P30GM154635-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P30GM154635-01
Clinical Studies
No Clinical Studies information available for 1P30GM154635-01
News and More
Related News Releases
No news release information available for 1P30GM154635-01
History
No Historical information available for 1P30GM154635-01
Similar Projects
No Similar Projects information available for 1P30GM154635-01